Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Hexima Ltd ( (AU:HXL) ) has shared an update.
Hexima Limited reported its quarterly activities for the period ended 31 March 2026, highlighting a shareholder-approved reduction of approximately $1.0 million in share capital via a cash distribution of 0.6 cents per share and a proportional share cancellation. The move, with cash payments to shareholders beginning on 29 April 2026, reflects a return of capital strategy that reduces the company’s equity base while providing immediate cash to investors.
The company closed the quarter with a cash balance of $1.33 million and recorded net operating cash outflows of $71,000, mainly due to compliance and professional fees, partially offset by interest income. Payments to related parties consisted of directors’ fees and remuneration at standard commercial rates, underscoring a low-operational, cost-containment posture that may signal ongoing wind-down or strategic review rather than active revenue-generating growth.
More about Hexima Ltd
Hexima Limited is an Australian-listed company focused on biotechnology, historically engaged in developing plant-derived and other biologic technologies. The company is currently in a compliance and capital management phase, with limited operating activities and an emphasis on preserving cash while meeting ongoing corporate obligations.
Technical Sentiment Signal: Hold
Current Market Cap: A$2.17M
Find detailed analytics on HXL stock on TipRanks’ Stock Analysis page.